| The relationship between diagnostic and antimicrobial stewardship : trusting blood cultures alone in diagnosis of cholangitis | Clinical microbiology and infection | | | 2025 | 41 | 1 |
|
| Inadequate imipenem dosing in patients with decreased kidney function : a global clinical pharmacokinetic study | Clinical microbiology and infection | | | 2025 | 5 | 60 |
|
| Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America | Frontiers in immunology | | | 2024 | 215 | 137 |
|
| Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM) : a systematic review and Delphi survey | Clinical microbiology and infection | | | 2024 | 81 | 0 |
|
| Urinary tract infection : from intellectual dead end to exciting new frontier ? | Clinical microbiology and infection | | | 2023 | 113 | 0 |
|
| How to use biomarkers of infection or sepsis at the bedside : guide to clinicians | Intensive care medicine | | | 2023 | 116 | 368 |
|
| On culture and blood cultures | Clinical microbiology and infection | | | 2023 | 87 | 0 |
|
| REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT' | BMC medical ethics | | | 2023 | 159 | 227 |
|
| Which trial do we need ? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women | Clinical microbiology and infection | | | 2023 | 97 | 0 |
|
| The urobiome in men and women : a clinical review | Clinical microbiology and infection | | | 2023 | 133 | 0 |
|
| Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability | Clinical microbiology and infection | | | 2023 | 122 | 0 |
|
| Translating clinical trial results to clinical practice during a pandemic | JAMA | | | 2023 | 79 | 0 |
|
| Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates : A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin | Open forum infectious diseases | | | 2023 | 98 | 472 |
|
| Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis | EClinicalMedicine | | | 2023 | 300 | 1,130 |
|
| Association between women's authorship and women's editorship in infectious diseases journals : a cross-sectional study | Lancet. Infectious diseases | | | 2022 | 106 | 0 |
|
| Is shorter always better ? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics | JAC-antimicrobial resistance | | | 2022 | 101 | 231 |
|
| Therapeutic drug monitoring and clinical outcomes in severely ill patients receiving amoxicillin: a single-centre prospective cohort study | International journal of antimicrobial agents | | | 2022 | 279 | 364 |
|
| Patient and Proxy Recall After Providing Written or Oral Informed Consent to Participate in an Interventional Trial | JAMA network open | | | 2022 | 144 | 109 |
|
| Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker study | The Lancet microbe | | | 2022 | 190 | 138 |
|
| How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study | Clinical microbiology and infection | | | 2022 | 206 | 166 |
|
| Prediction models in CMI | Clinical microbiology and infection | | | 2022 | 179 | 0 |
|
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | | | 2022 | 100 | 0 |
|
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | | | 2022 | 452 | 208 |
|
| Representation of women in editorial boards of infectious disease and microbiology journals-cross-sectional study | Clinical microbiology and infection | | | 2022 | 138 | 0 |
|
| Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure | Antibiotics | | | 2022 | 116 | 246 |
|
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | | 2022 | 203 | 208 |
|
| Maladies infectieuses | Revue médicale suisse | | | 2021 | 395 | 121 |
|
| Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine | Vaccines | | | 2021 | 163 | 103 |
|
| Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study | Multiple Sclerosis and Related Disorders | | | 2021 | 354 | 206 |
|
| Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study | Journal of travel medicine | | | 2021 | 230 | 0 |
|
| Using external data to assess the external validity of a randomised controlled trial | Infectious diseases | | | 2021 | 197 | 0 |
|
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | | | 2021 | 443 | 326 |
|
| Risk factors for treatment failure in women with uncomplicated lower urinary tract infection | PloS one | | | 2021 | 220 | 529 |
|
| Joint ESCMID, FEMS, IDSA, ISID and SSI position paper on the fair handling of career breaks among physicians and scientists when assessing eligibility for early-career awards | Clinical microbiology and infection | | | 2021 | 258 | 170 |
|
| Patient engagement in clinical research : Geneva University Hospitals’ model | Regulatory affairs watch | | | 2021 | 28 | 147 |
|
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | | | 2021 | 323 | 236 |
|
| A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety | EFORT open reviews | | | 2021 | 262 | 431 |
|
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | | | 2021 | 413 | 265 |
|
| Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trial | EBioMedicine | | | 2021 | 255 | 186 |
|
| Abandoned trials in infection diseases and clinical microbiology: a call for action | Clinical microbiology and infection | | | 2021 | 147 | 229 |
|
| Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients | Pharmaceutics | | | 2021 | 181 | 228 |
|
| Investigator-initiated randomized controlled trials in infectious diseases: better value for money for registration trials of new antimicrobials | Clinical Infectious Diseases | | | 2020 | 212 | 812 |
|
| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines | | | 2020 | 482 | 142 |
|
| Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | Clinical pharmacokinetics | | | 2020 | 171 | 218 |
|
| Risk of MS relapse after yellow fever vaccination: A self-controlled case series | Neurology: Neuroimmunology & Neuroinflammation | | | 2020 | 259 | 207 |
|
| Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial | Clinical Microbiology and Infection | | | 2020 | 337 | 259 |
|
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) | Clinical Infectious Diseases | | | 2020 | 507 | 388 |
|
| Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial | JAMA (Journal of the American Medical Association) | | | 2020 | 425 | 843 |
|
| A systematic review assessing the under-representation of elderly adults in COVID-19 trials | BMC geriatrics | | | 2020 | 17 | 164 |
|
| Dexamethasone and remdesivir: finding method in the COVID-19 madness | The Lancet microbe | | | 2020 | 256 | 52 |
|
| The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study | The Journal of antimicrobial chemotherapy | | | 2019 | 501 | 0 |
|
| Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009–2016) | Swiss Medical Weekly | | | 2019 | 447 | 416 |
|
| Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study | Clinical microbiology and infection | | | 2019 | 252 | 189 |
|
| Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial | JAMA (Journal of the American Medical Association) | | | 2018 | 561 | 1 |
|
| Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study | The Lancet Infectious Diseases | | | 2018 | 516 | 0 |
|
| Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know? | Expert Review of Vaccines | | | 2018 | 375 | 0 |
|
| Therapeutic drug monitoring of beta-lactams and other antibiotics in the intensive care unit: which agents, which patients and which infections? | Drugs | | | 2018 | 404 | 0 |
|
| Cefiderocol in context | The Lancet Infectious Diseases | | | 2018 | 331 | 1 |
|
| Antibiotic Treatment for Uncomplicated Urinary Tract Infections-Reply | JAMA (Journal of the American Medical Association) | | | 2018 | 356 | 1 |
|
| Closing the evidence gap in infectious disease: point-of-care randomization and informed consent | Clinical microbiology and infection | | | 2017 | 537 | 0 |
|
| Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy | JAMA Internal Medicine | | | 2017 | 459 | 0 |
|
| A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa | Science Translational Medicine | | | 2017 | 641 | 2 |
|
| Infections urinaires basses non associées aux sondes urinaires chez l'homme. Urétrite, cystite et prostatite | Revue médicale suisse | | | 2017 | 1,072 | 782 |
|
| Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey | PLOS ONE | | | 2017 | 516 | 240 |
|
| Inequality dynamics in the workplace among microbiologists and infectious disease specialists: a qualitative study in five European countries | Clinical microbiology and infection | | | 2017 | 426 | 252 |
|
| Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials | Clinical microbiology and infection | | | 2017 | 612 | 0 |
|
| PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia | BMJ Open | | | 2017 | 577 | 244 |
|
| Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial | The Lancet Infectious Diseases | | | 2017 | 568 | 0 |
|
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine | | | 2016 | 1,232 | 372 |
|
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | | 2016 | 938 | 302 |
|
| L'épidémie de la maladie du virus Ebola et le vaccin VSV-EBOV : un essai clinique de phase I dans une situation d'urgence | | | | 2016 | 737 | 678 |
|
| An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model | PloS one | | | 2016 | 577 | 342 |
|
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | | | 2015 | 710 | 0 |
|
| Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials | The journal of antimicrobial chemotherapy | | | 2015 | 634 | 0 |
|
| Therapeutic drug monitoring of the ß-lactam antibiotics: what is the evidence and which patients should we be using it for? | The journal of antimicrobial chemotherapy | | | 2015 | 513 | 0 |
|
| Infectiologie en 2014: une année virale | Revue médicale suisse | | | 2015 | 509 | 2 |
|
| Augmented renal clearance, low ß-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study | International journal of antimicrobial agents | | | 2015 | 840 | 3 |
|
| Antibiothérapie par voie sous-cutanée chez le patient âgé | Revue médicale suisse | | | 2014 | 467 | 0 |
|
| Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010 | The journal of antimicrobial chemotherapy | | | 2014 | 601 | 0 |
|
| Polymerase-chain reaction/electrospray ionization-mass spectrometry for the detection of bacteria and fungi in bronchoalveolar lavage fluids: a prospective observational study | Clinical microbiology and infection | | | 2014 | 578 | 0 |
|
| An international, multicentre survey of ß-lactam antibiotic therapeutic drug monitoring practice in intensive care units | The journal of antimicrobial chemotherapy | | | 2014 | 638 | 0 |
|
| Assisted knowledge discovery for the maintenance of clinical guidelines | PloS one | | | 2013 | 1,017 | 382 |
|
| Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system | The journal of antimicrobial chemotherapy | | | 2013 | 605 | 0 |
|
| Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum | Antimicrobial resistance and infection control | | | 2013 | 693 | 996 |
|
| A simulation-based assessment of strategies to control Clostridium difficile transmission and infection | PloS one | | | 2013 | 673 | 386 |
|
| Assister la création de guides de bonnes pratiques par des techniques de recherche d'information | Swiss medical informatics | | | 2012 | 866 | 0 |
|
| Beads vs bugs? | Chest | | | 2012 | 539 | 0 |
|
| Treatment of HIV infection with drugs for HSV-2 infection | Lancet | | | 2010 | 541 | 0 |
|
| Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients | The journal of antimicrobial chemotherapy | | | 2010 | 544 | 0 |
|
| Guidelines for vancomycin use | Clinical infectious diseases | | | 2010 | 578 | 0 |
|
